Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis. (23rd February 2018) - Liu, C; Wang, L; Zhuang, J; Liu, L; Zhou, C; Feng, F; Sun, C